Pfizer and BioNTech expect to ask for emergency permission within a matter of days to start distributing their COVID-19 vaccine, the companies said Wednesday—as they released a trove of new data showing the vaccine is about 95% effective.

A request to the Food and Drug Administration (FDA), which evaluates all new medications brought to market, would be a dramatic milestone.